Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability

Tumor Biology

Volumn 37, Issue 8, 2016, Pages 10357-10364

  Govatati, Suresh ^a   Malempati, Sravanthi ^b   Saradamma, Bulle ^a   Divyamaanasa, Dasi ^c   Naidu, B Prathap ^b   Bramhachari, Pallaval Veera ^b   Narayana, Nagesh ^d   Shivaji, Sisinthy ^d,e   Bhanoori, Manjula ^f   Tamanam, Raghava Rao ^g   Rao, Pasupuleti Sreenivasa ^h   Nallanchakravarthula, Varadacharyulu ^a  

^a SRI KRISHNADEVARAYA UNIVERSITY   (India)

^b KRISHNA UNIVERSITY   (India)

^c GITAM UNIVERSITY   (India)

^d CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^e L V PRASAD EYE INSTITUTE   (India)

^f OSMANIA UNIVERSITY   (India)

^g ANDHRA UNIVERSITY   (India)

^h NARAYANA MEDICAL COLLEGE   (India)

Author keywords

Colorectal cancer; D loop; Mitochondria; Mn SOD; Polymorphism

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MN SOD GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; T16189C GENE; WESTERN BLOTTING; ADENOCARCINOMA; AGED; BIOSYNTHESIS; COLORECTAL TUMOR; ENZYMOLOGY; GENETICS; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 84957605692     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-4918-0     Document Type: Article

References (51)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87.
2. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.
3. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361:2449–60.
4. Govatati S, Singamsetty GK, Nallabelli N, Malempati S, Rao PS, Madamchetty VKK, et al. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case–control study. Tumor Biol. 2014;35:12059–67.
5. Singamsetty GK, Malempati S, Bhogadhi S, Kondreddy R, Govatati S, Tangudu NK, et al. TP53 alterations and colorectal cancer predisposition in south Indian population: a case–control study. Tumor Biol. 2014;35:2303–11.
6. Pelicci PG, Dalton P, Giorgio M. The other face of ROS: a driver of stem cell expansion in colorectal cancer. Cell Stem Cell. 2013;12:761–73.
7. Tipirisetti NR, Rao KL, Govatati S, Govatati S, Vuree S, Singh L, et al. Mitochondrial genome variations in advanced stage breast cancer: a case-control study. Mitochondrion. 2013;13:372–8.
8. Govatati S, Deenadayal M, Shivaji S, Bhanoori M. Mitochondrial NADH:ubiquinone oxidoreductase alterations are associated with endometriosis. Mitochondrion. 2013;13:782–90.
9. Govatati S, Tipirisetti TR, Perugu S, Kodati VL, Deenadayal M, Vishnupriya S, et al. Mitochondrial genome variations in advanced stage endometriosis: a study in South Indian population. PLoS One. 2012;7:e40668.
10. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407.
11. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–52.
12. Anderson S, Bankier AT, Barrell BG, De Bruijn MHL, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.
13. Lightowlers RN, Chinnery PF, Thunball DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 1997;13:450–5.
14. Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene. 2006;25:4663–74.
15. Clayton DA. Transcription and replication of mitochondrial DNA. Hum Reprod. 2000;2:11–7.
16. Tipirisetti NR, Govatati S, Pullari P, Malempati S, Thupurani MK, Perugu S, et al. Mitochondrial control region alterations and breast cancer risk: a study in south Indian population. PLoS One. 2014;9:e85363.
17. Govatati S, Deenadayal M, Shivaji S, Bhanoori M. Mitochondrial displacement loop alterations are associated with endometriosis. Fertil Steril. 2013;99:1980–6.
18. Chen JB, Yang YH, Lee WC, Liou CW, Lin TK, Chung YH, et al. Sequence-based polymorphisms in the mitochondrial D-loop and potential SNP predictors for chronic dialysis. PLoS One. 2012;7:e41125.
19. Mueller EE, Eder W, Ebner S, Schwaiger E, Santic D, Kreindl T, et al. The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One. 2011;6:e16455.
20. Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK. Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Color Dis. 2009;24:623–8.
21. Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Dis Colon Rectum. 2009;52:526–30.
22. Nicotera TM, Privalle C, Wang TC, Oshimura M, Barrett JC. Differential proliferative responses of Syrian hamster embryo fibroblasts to paraquat-generated superoxide radicals depending on tumor suppressor gene function. Cancer Res. 1994;54:3884–8.
23. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335–44.
24. Halliwell B, Gutteridge J. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press; 1999.
25. Sreevalsan S, Safe S. Reactive oxygen species and colorectal cancer. Curr Color Cancer Rep. 2013;9:350–7.
26. Inokuma T, Haraguchi M, Fujita F, Tajima Y, Kanematsu T. Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology. 2009;56:343–7.
27. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7:97–110.
28. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 2000;407:390–5.
29. Janssen AM, Bosman CB, van Duijn W, de Ruit MM O-v, Kubben FJ, Griffioen G, et al. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res. 2000;6:3183–92.
30. Van Driel BE, Lyon H, Hoogenraad DC, Anten S, Hansen U, Van Noorden CJ. Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radic Biol Med. 1997;23:435–44.
31. Janssen AM, Bosman CB, Sier CF, Griffioen G, Kubben FJ, Lamers CB, et al. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer. 1998;78:1051–7.
32. Toh Y, Kuninaka S, Oshiro T, Ikeda Y, Nakashima H, Baba H, et al. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol. 2000;17:107–12.
33. International Union Against Cancer (UICC): In: TNM classification of malignant tumours. Hermaek P, Hutter RVP and Sobin LH (eds.). Berlin: Springer-Verlag, 1998.
34. Govatati S, Chakravarty B, Deenadayal M, Kodati VL, Latha M, Shivaji S, et al. p53 and risk of endometriosis in Indian women. Genet Test Mol Biomarkers. 2012;16:865–73.
35. Govatati S, Tangudu NK, Deenadayal M, Chakravarty B, Shivaji S, Bhanoori M. Association of E-cadherin single nucleotide polymorphisms with the increased risk of endometriosis in Indian women. Mol Hum Reprod. 2012;18:280–7.
36. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999;23:147.
37. Govatati S, Challa K, Reddy SB, Pramod K, Deenadayal M, Chakravarty B, et al. BRCA1 alterations are associated with endometriosis, but BRCA2 alterations show no detectable endometriosis risk: a study in Indian population. J Assist Reprod Genet. 2015;32:277–85.
38. Govatati S, Kodati VL, Deenadayal M, Chakravarty B, Shivaji S, Bhanoori M. Mutations in the PTEN tumor gene and risk of endometriosis: a case–control study. Hum Reprod. 2014;29:324–36.
39. Stoneking M. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet. 2000;7:1029–32.
40. Kang D, Miyako K, Kai Y, Irie T, Takeshige K. In vivo determination of replication origins of human mitochondrial DNA by ligation-mediated polymerase chain reaction. J Biol Chem. 1997;272:15275–9.
41. Wang Y, Liu VW, Ngan HY, Nagley P. Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers. Ann N Y Acad Sci. 2005;1042:123–9.
42. Xu B, Clayton DA. RNA-DNA hybrid formation at the human mitochondrial heavy-strand origin ceases at replication start sites: an implication for RNA-DNA hybrids serving as primers. EMBO J. 1996;15:3135–43.
43. Pham XH, Farge G, Shi Y, Gaspari M, Gustafsson CM, Falkenberg M. Conserved sequence box II directs transcription termination and primer formation in mitochondria. J Biol Chem. 2006;281:24647–52.
44. Berger C, Hatzer-Grubwieser P, Hohoff C, Parson W. Evaluating sequence-derived mtDNA length heteroplasmy by amplicon size analysis. Forensic Sci Int Genet. 2011;5:142–5.
45. Fernandez-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol. 2003;88:41–56.
46. Liou CW, Lin TK, Chen JB, Tiao MM, Weng SW, Chen SD, et al. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet. 2010;47:723–8.
47. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, Abrosimov AY, Lushnikov EF, et al. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res. 2002;62:7031–41.
48. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology. 1998;51:1525–8.
49. Holt IJ, Lorimer HE, Jacobs HT. Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA. Cell. 2000;100:515–24.
50. Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, et al. What causes mitochondrial DNA deletions in human cells? Nat Genet. 2008;40:275–9.
51. Chen T, He J, Shen L, Fang H, Nie H, Jin T, et al. The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet. 2011;12:8.